IMMUNOVANT INC (IMVT) Stock Cash Flow
NASDAQ:IMVT - Nasdaq - US45258J1025 - Common Stock - Currency: USD
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -413.84M | -259.34M | -210.96M | -156.73M | -107.43M | |||
| Depreciation Amortization | 377.00K | 231.00K | 190.00K | 130.00K | 70.00K | |||
| Change In Working Capital | -12.03M | 2.63M | -10.85M | 15.14M | 4.57M | |||
| Taxes Paid | 1.20M | 509.00K | N/A | 0.00 | 170.00K | |||
| Other non cash items | 49.62M | 42.25M | 33.43M | 35.35M | 19.47M | |||
| OPERATING CASH FLOW | -375.87M | -214.23M | -188.19M | -106.11M | -83.33M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -759.00K | -360.00K | -200.00K | -250.00K | -210.00K | |||
| INVESTING CASH FLOW | -759.00K | -360.00K | -200.00K | -250.00K | -210.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -3.19M | |||
| Stock Issued/Repurchased | 454.81M | 478.44M | 71.16M | 0.00 | 386.44M | |||
| Other Financing Activity | -319.00K | -6.01M | -270.00K | 200.13M | -140.00K | |||
| FINANCING CASH FLOW | 454.49M | 472.43M | 70.89M | 200.13M | 383.11M | |||
| Exchange Rate Effect | 747.00K | 993.00K | 220.00K | -90.00K | N/A | |||
| CHANGE IN CASH | 78.61M | 258.83M | -117.28M | 93.68M | 299.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -375.87M | -214.23M | -188.19M | -106.11M | -83.33M | |||
| Capital Expenditure | -759.00K | -360.00K | -200.00K | -250.00K | -210.00K | |||
| FREE CASH FLOW | -376.63M | -214.59M | -188.39M | -106.36M | -83.54M | |||
All data in USD